Soros Partners Llc Perseus

Soros Partners Llc Perseus is 10% at MAP Pharmaceuticals, Inc. (MAPP). They have made 1 open-market trade across 1 company since 2010, most recently 2010-05-11.

CIK 0001250191

Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.

0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.

Current Position

Ticker	Shares	Value
BIVN	3,375,044	—
MAPP	1,826,169	—
Total		$0

Shares reported on the most recent Form 4, priced at the 2010-05-13 close. 2 holdings could not be priced and are excluded from the total.

Get alerted the next time Soros Partners Llc Perseus files

Alerts when they file, saved screens, and the strategy books. 7-day free trial, no credit card required.

Follow Soros Partners Llc Perseus

Sell Track Record

Filings1

No scored decision-sell filings

Decision sells only — a first sale after buying the stock, or a sale by a fund or 10% owner. Ordinary sales by officers and directors show no relationship to what the stock does next, so they are counted but not scored.